IndiaOne Finance - Company Dashboard

Governance Classic Home

SMS Lifesciences India LtdPharmaceuticalsINE320X01016Standalone₹1480.15+6.85 (+0.46%)Jun-26

Valuation

Market Cap₹452.77 Cr

TTM PE28.56x

Forward PE31.22x

PEG-2.64

Book Value₹650.15

P/B2.30x

TTM EPS₹52.44

Fwd EPS₹47.97

TTM Revenue₹289.77 Cr

TTM PAT₹15.87 Cr

TTM EBITDA₹38.20 Cr

TTM EBIT₹27.16 Cr

Last Qtr PAT₹3.24 Cr

Last Qtr EBITDA₹9.64 Cr

Last Qtr EBIT₹6.63 Cr

Profitability

ROE8.07%

ROCE10.00%

TTM NPM5.48%

TTM EBITDA %13.18%

Curr OPM4.77%

Last OPM3.53%

Curr NPM—

Last NPM—

Curr EPS₹10.71

Last EPS₹7.39

Balance sheet

Equity₹3.02 Cr

Reserve₹193.54 Cr

Total Debt₹84.02 Cr

D/E0.43x

Interest %55.86%

Curr Interest₹1.81 Cr

Price / range

Close₹1497.60

vs 52W High-15.58%

vs 52W Low+36.07%

MA50—

MA200—

Returns

1D+0.31%

1W-1.14%

1M+1.30%

3M+2.08%

6M+17.47%

1Y+22.36%

2Y-1.31%

3Y+182.81%

5Y+105.19%

Diwali+17.45%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	148.17	3.58%
DIVISLAB	9375.00	₹2.49L Cr	84.62	17.55%
TORNTPHARM	4840.00	₹1.84L Cr	78.80	25.43%
ZYDUSLIFE	1160.00	₹1.16L Cr	33.21	12.96%
CIPLA	1394.50	₹1.13L Cr	36.64	8.93%
LAURUSLABS	1954.00	₹1.06L Cr	120.92	16.46%
AUROPHARMA	1734.00	₹99.77K Cr	38.79	6.84%
DRREDDY	1185.00	₹98.91K Cr	148.68	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	67.83-14.2%	63.38	80.72	77.84	79.04	300.99
Other Income	0.46	0.97	0.08	0.44	1.01	1.42
Total Income	68.29-14.7%	64.35	80.80	78.28	80.05	302.41
Interest	1.81	1.34	1.46	1.51	1.73	6.03
Expenditure	-63.01+13.2%	-61.18	-73.31	-71.23	-72.57	-277.22
PBDT	0	0	0	0	0	0
EBITDA	9.64-11.0%	6.20	11.56	10.80	10.83	40.46
Depreciation	-3.01	-2.66	-2.69	-2.68	-2.63	-10.66
EBIT	6.63-19.1%	3.54	8.87	8.12	8.20	29.80
PBT	5.28-29.4%	3.18	7.49	7.05	7.48	25.19
Tax	-2.04	-0.94	-2.08	-2.07	-2.32	-7.41
Equity	0	0	0	0	3.02	0
OPM	7.78	5.01	9.28	9.05	9.34	8.00
Net Profit	3.24-37.2%	2.24	5.41	4.98	5.16	17.78
NPM	4.77	3.53	6.70	6.39	6.45	6.00
EPS	10.71-37.2%	7.39	17.88	16.46	17.06	58.80

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	300.99-9.7%	333.37+11.1%	300-4.8%	315.24-8.8%	345.63+32.8%	260.26
Other Income	1.42	3.95	3.84	2.88	1.54	1.33
Total Income	302.41-10.3%	337.32+11.0%	303.84-4.5%	318.12-8.4%	347.16+32.7%	261.59
Expenditure	-277.22+9.8%	-307.28-7.9%	-284.73+5.7%	-302.10+7.6%	-326.88-34.9%	-242.23
Interest	-6.03	-7.88	-8.90	-5.09	-4.63	-4.50
PBDT	0	0	0	0	0	0
EBITDA	40.46-8.5%	44.23+28.5%	34.42+30.4%	26.40-15.8%	31.37+5.5%	29.74
Depreciation	-10.66	-10.26	-10.25	-8.17	-7.99	-7.21
EBIT	29.80-12.3%	33.97+40.5%	24.17+32.6%	18.23-22.0%	23.38+3.8%	22.53
PBT	25.19-16.1%	30.04+57.2%	19.11+4.0%	18.37-44.3%	32.98+70.4%	19.35
Tax	-7.41	-8.67	-6.05	-5.16	-7.60	-6.19
Equity	0	3.02	0	0	0	0
OPM (%)	8.00	8.91	6.00	6.00	9.00	7.00
Net Profit	17.78-16.8%	21.37+63.5%	13.07-1.1%	13.22-47.9%	25.38+92.7%	13.17
NPM (%)	6.00	6.34	4.00	4.00	7.00	5.00
EPS (Rs)	58.80-16.8%	70.69+63.6%	43.22-1.1%	43.72-47.9%	83.95+92.7%	43.56
CEPS	58.80	70.69	43.22	43.72	83.95	43.56

Metric	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	FY24-25
Revenue	94.78+12.0%	81.37	82.50	89.11	84.60	344.72
Other Income	0.18	0.42	1	2.34	0.06	4.86
Total Income	94.97+12.2%	81.79	83.50	91.45	84.66	349.58
Interest	1.54	1.62	1.87	2.03	2.14	8.71
Expenditure	-86.19-10.9%	-73.30	-76.48	-87.52	-77.74	-323.39
PBDT	0	0	0	0	0	0
EBITDA	14.04+10.0%	13.58	11.71	7.42	12.76	45.04
Depreciation	-3.91	-3.89	-3.82	-3.80	-3.76	-15
EBIT	10.13+12.6%	9.69	7.89	3.62	9	30.04
PBT	8.78+26.9%	8.49	7.02	3.93	6.92	26.19
Tax	-2.13	-2.07	-2.64	-0.45	-2.06	-7.46
Equity	0	0	3.02	3.02	0	3.02
OPM	9.24	10.38	8.41	4.30	8.17	7.49
Net Profit	6.65+37.1%	6.43	4.38	3.48	4.85	18.73
NPM	7.00	7.86	5.25	3.81	5.73	5.36
EPS	21.89+21.1%	20.19	13.75	9.83	18.08	66.51

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21	FY 19-20
Revenue	344.72+12.7%	305.96-3.0%	315.56-9.8%	349.75+31.7%	265.59+1.8%	260.78
Other Income	4.86	3.83	3.07	2.07	1.78	2.28
Total Income	349.58+12.8%	309.79-2.8%	318.63-9.4%	351.81+31.6%	267.37+1.6%	263.06
Expenditure	-323.39-7.8%	-299.94+1.5%	-304.39+8.3%	-331.77-33.9%	-247.81+0.2%	-248.39
Interest	-8.71	-10.16	-6.80	-6.17	-4.53	-5.14
PBDT	0	0	0	0	0	0
EBITDA	45.04+44.7%	31.12+8.2%	28.76-15.8%	34.16+13.2%	30.17+18.8%	25.39
Depreciation	-15	-14.94	-10.79	-10.01	-7.86	-7.86
EBIT	30.04+85.7%	16.18-10.0%	17.97-25.6%	24.15+8.2%	22.31+27.3%	17.53
PBT	26.19+165.9%	9.85-40.6%	16.59-49.3%	32.73+67.2%	19.57+33.4%	14.67
Tax	-7.46	-3.52	-5.22	-7.43	-6.01	-4.49
Equity	3.02	0	0	0	0	0
OPM (%)	7.49	3.18	5.21	9.30	7.32	5.58
Net Profit	18.73+195.9%	6.33-44.4%	11.38-55.0%	25.28+86.4%	13.56+33.2%	10.18
NPM (%)	5.36	2.04	3.57	7.19	5.07	3.87
EPS (Rs)	66.51+121.1%	30.08-20.7%	37.92-54.7%	83.68+86.6%	44.84+33.1%	33.68
CEPS	66.51	30.08	37.92	83.68	44.84	33.68

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2025	Final Dividend	1.5	24 Sep 2025
2024	Final Dividend	1.5	23 Sep 2024
2023	Final Dividend	1.5	22 Sep 2023
2022	Final Dividend	1.5	22 Sep 2022
2021	Final Dividend	1.5	20 Sep 2021
2019	Final Dividend	1.5	19 Sep 2019

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split